Does Ondansetron Injection Need Refrigeration? Check the Exact Product

Refrigeration is not required for the two unopened ondansetron injection presentations compared here: Pfizer/Hospira NDC 0409-4755-03 and Apotex-labeled, Qilu-manufactured NDC 60505-6130-5. [1] [2] The Pfizer/Hospira label specifies 20-25°C and separately permits 2-8°C, with light protection and carton retention until use. [1] The Apotex/Qilu label specifies 2-30°C and light protection. [2] Both allow refrigerated conditions, but their instructions must remain separate. These unopened-product instructions do not decide excursions or diluted-solution stability.

A shared drug name can make copying an existing storage record seem reasonable. With these two products, even strength, vial volume and package count line up. That still leaves a question the short listing cannot answer: what does the exact supplied label say?

AI-created fictional receiving-area discussion across an empty cart. No medicine storage or shipment acceptance is demonstrated.

This comparison concerns unopened manufacturer-supplied vials. An exposure during shipping, an entered vial or a prepared solution raises a different question. The ranges below do not decide whether a particular shipment is acceptable or how long a preparation remains usable.

Match the product before extracting the storage text

The Pfizer label identifies 0409-4755-03 as a tray of 25 single-dose 2 mL vials, each labeled 4 mg/2 mL (2 mg/mL). The Apotex record identifies 60505-6130-5 as a carton of 25 single-dose 2 mL vials at the same nominal strength. Clint lists both as Box/25, so preserve the label's package terminology and confirm the supplied purchasing unit. [1] [2] [3]

The second label names Qilu Pharmaceutical (Hainan) Co., Ltd. as manufacturer and Apotex Corp. as the company for which it is manufactured. [2]

Preserve the complete instruction for each unopened product

A useful storage reference carries the qualifying words beside the temperatures. In the first record, the additional permission to refrigerate belongs with the room-temperature instruction. In both records, light protection belongs in the same excerpt that staff will consult at receiving. A temperature-only cell leaves out a condition the label supplied.

Two unopened products, two storage statements

Unopened products / source-matched intervals

Paraphrases of each label's section 16 for unopened product. Both permit refrigerated conditions. Do not combine the ranges or use this comparison to accept an excursion or establish prepared-product stability. Pfizer/Hospira label: [1]. Apotex/Qilu label: [2].

PRACTICE + SCIENCE / VISUAL REFERENCE

Keep two storage records separate.

Exact product identityComplete storage instructionSource and date checked

Conceptual artwork created with AI. Separate reference folders and cards with a magnifying glass and generic vial. Product identity and instructions come from the cited sources, not this illustration.

A worked receiving-record correction

Consider a hypothetical office whose reference sheet has one row labeled "ondansetron injection." Staff create a second purchasing entry by copying the first row because the new listing also says 4 mg/2 mL and 25 vials. The copied text now appears to have been verified for a product whose label was never consulted.

A better output is two distinct product records, each carrying its own identifier, source link, storage text and protection requirements. Use the two source-matched entries above to populate those fields. Keep the Pfizer/Hospira room-temperature instruction and separate permission to refrigerate together. Retain the single stated interval in the Apotex/Qilu entry; do not create a combined range that neither product record actually states.

Record the label checked and the check date beside each product's instructions. Those notes document the reference used; they do not establish that a shipment was handled correctly.

If the question instead concerns an unknown shipping temperature or time outside established storage, keep that exposure question visible and route it to the responsible practice lead for product-specific manufacturer guidance. Matching the NDC and reading the storage section supplies context for that review; it does not provide an excursion acceptance decision.

Clint product reference

Use Clint's Ondansetron category to locate the already approved product by its exact NDC. Confirm the supplied purchasing unit and current availability, then retain that product's own label in the receiving reference. [3]

Sources and scope

1. Pfizer ondansetron injection prescribing information. Section 16; revised August 2025. Pfizer/Hospira unopened-product storage and sale presentation.
2. Apotex-labeled ondansetron prescribing information. Section 16 and company-role text. Body revised October 2025; page header updated August 26, 2025; archive publication November 17, 2025. These are separate displayed dates; their order is not explained by the source.
3. Clint Ondansetron category. Navigation and Box/25 listing terminology only. Both exact sale NDCs are displayed; live stock is unverified.

Sources rechecked October 5, 2026. This professional reference concerns product identification and office records. Product-specific labeling and the responsible practice team govern clinical and handling decisions.